ASSERTIO THERAPEUTICS

Summary

Assertio Therapeutics operates as a pharmaceutical company. The Company develops and markets orphan drugs and therapeutic solutions. Assertio Therapeutics serves patients in the United States.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 318 M

Avg. Deal Size£ 159 M

Market Context

Senior Management

Arthur Higgins
President and CEO
Daniel Peisert
CEO
Dan Peisert
CFO

Sort

25 Apr 2023|United States|Biotechnology

Target: SPECTRUM PHARMACEUTICALS

Bidder: ASSERTIO THERAPEUTICS

10 Service Providers

5 Target | 5 Bidder

48 Dealmakers

9 Target | 39 Bidder

£ 232 M

Value

16 Mar 2020|United States|Pharmaceuticals

Target: ZYLA LIFE SCIENCES

Bidder: ASSERTIO THERAPEUTICS

7 Service Providers

3 Target | 4 Bidder

28 Dealmakers

17 Target | 11 Bidder

£ 85 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy